TAG / FDA

A surge in overdoses tied to the synthetic compound 7-OH has triggered emergency action in Los Angeles County. Regulators warn that products sold as natural remedies mask opioid-like disasters.

Factors like sex, race or foster care status didn’t explain the fivefold jump in psychotropic stacking. The results expose a system primed to drug children rather than help them.

From smoke shops to health food stores, highly addictive kratom formulas exploit legal loopholes, putting communities across the US in danger.

A landmark reform shuts down deceptive drug ads that fueled overprescribing, misinformation and billions in profits for Big Pharma.

From gummies to wrongful death lawsuits, the billion-dollar rise of “gas station heroin” is colliding with bans, bereaved families and the FDA’s harshest crackdown yet.

A 10‑member FDA panel met amid mounting evidence that antidepressants may impair fetal brain development.

Psychiatrists push for electroshock on children—even as global bodies condemn it, courts rebuke it and victims recount the brain damage it leaves behind.

Evidence suggests drugmakers manipulated trials and government failed to respond while patients live with permanent loss of sexual function.

Purdue prepares to pay up, leaving unanswered questions about justice, accountability and how hundreds of thousands of lives might have been saved if regulators had acted sooner.

Six years after doctors petitioned for Post-SSRI Sexual Dysfunction label warnings, the FDA has done nothing. Now, victims are speaking out—before more lives are destroyed.